120 related articles for article (PubMed ID: 11948474)
1. Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody.
Olson KA; Byers HR; Key ME; Fett JW
Int J Cancer; 2002 Apr; 98(6):923-9. PubMed ID: 11948474
[TBL] [Abstract][Full Text] [Related]
2. Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin.
Olson KA; Byers HR; Key ME; Fett JW
Clin Cancer Res; 2001 Nov; 7(11):3598-605. PubMed ID: 11705882
[TBL] [Abstract][Full Text] [Related]
3. Angiogenin antagonists prevent tumor growth in vivo.
Olson KA; Fett JW; French TC; Key ME; Vallee BL
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):442-6. PubMed ID: 7831307
[TBL] [Abstract][Full Text] [Related]
4. Chimeric anti-angiogenin antibody cAb 26-2F inhibits the formation of human breast cancer xenografts in athymic mice.
Piccoli R; Olson KA; Vallee BL; Fett JW
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4579-83. PubMed ID: 9539780
[TBL] [Abstract][Full Text] [Related]
5. Organogenesis and angiogenin.
Vallee BL; Riordan JF
Cell Mol Life Sci; 1997 Oct; 53(10):803-15. PubMed ID: 9413551
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer-derived angiogenin stimulates the invasion of prostate fibroblasts.
Jones ML; Ewing CM; Isaacsa WB; Getzenberg RH
J Cell Mol Med; 2012 Jan; 16(1):193-201. PubMed ID: 21352472
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice.
Karashima T; Sweeney P; Slaton JW; Kim SJ; Kedar D; Izawa JI; Fan Z; Pettaway C; Hicklin DJ; Shuin T; Dinney CP
Clin Cancer Res; 2002 May; 8(5):1253-64. PubMed ID: 12006546
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
Plonowski A; Schally AV; Nagy A; Sun B; Szepeshazi K
Cancer Res; 1999 Apr; 59(8):1947-53. PubMed ID: 10213505
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice.
Olson KA; French TC; Vallee BL; Fett JW
Cancer Res; 1994 Sep; 54(17):4576-9. PubMed ID: 8062244
[TBL] [Abstract][Full Text] [Related]
11. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
[TBL] [Abstract][Full Text] [Related]
12. A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation.
Yoshioka N; Wang L; Kishimoto K; Tsuji T; Hu GF
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14519-24. PubMed ID: 16971483
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model.
Melnyk O; Zimmerman M; Kim KJ; Shuman M
J Urol; 1999 Mar; 161(3):960-3. PubMed ID: 10022734
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.
Inoue K; Slaton JW; Perrotte P; Davis DW; Bruns CJ; Hicklin DJ; McConkey DJ; Sweeney P; Radinsky R; Dinney CP
Clin Cancer Res; 2000 Dec; 6(12):4874-84. PubMed ID: 11156247
[TBL] [Abstract][Full Text] [Related]
15. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.
Perrotte P; Matsumoto T; Inoue K; Kuniyasu H; Eve BY; Hicklin DJ; Radinsky R; Dinney CP
Clin Cancer Res; 1999 Feb; 5(2):257-65. PubMed ID: 10037173
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of angiogenin in prostate cancer and its precursors.
Katona TM; Neubauer BL; Iversen PW; Zhang S; Baldridge LA; Cheng L
Clin Cancer Res; 2005 Dec; 11(23):8358-63. PubMed ID: 16322296
[TBL] [Abstract][Full Text] [Related]
17. In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors.
Wu JD; Odman A; Higgins LM; Haugk K; Vessella R; Ludwig DL; Plymate SR
Clin Cancer Res; 2005 Apr; 11(8):3065-74. PubMed ID: 15837762
[TBL] [Abstract][Full Text] [Related]
18. In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen.
Li Y; Tian Z; Rizvi SM; Bander NH; Allen BJ
Prostate Cancer Prostatic Dis; 2002; 5(1):36-46. PubMed ID: 15195129
[TBL] [Abstract][Full Text] [Related]
19. Development of antiangiogenin peptide using a phage-displayed peptide library.
Gho YS; Lee JE; Oh KS; Bae DG; Chae CB
Cancer Res; 1997 Sep; 57(17):3733-40. PubMed ID: 9288781
[TBL] [Abstract][Full Text] [Related]
20. Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin.
Hadaschik BA; Ettinger S; Sowery RD; Zoubeidi A; Andersen RJ; Roberge M; Gleave ME
Int J Cancer; 2008 May; 122(10):2368-76. PubMed ID: 18240145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
